PC PHARMA PLC reported audited company earnings results for the first half and full year ended March 31, 2012. For the first half, the company reported profit from operating activities of LKR 95,965,056, net profit before taxation of LKR 81,601,354, net profit of LKR 46,360,906 or LKR 0.46 per share on revenue of LKR 336,000,853 against profit from operating activities of LKR 78,974,846, net profit before taxation of LKR 68,503,391, net profit of LKR 38,703,685 or LKR 7.69 per share on revenue of LKR 281,066,403 for the same period a year ago. For the year, the company reported profit from operating activities of LKR 222,595,936, net profit before taxation of LKR 196,460,418, net profit of LKR 129,059,432 or LKR 1.28 per share on revenue of LKR 659,855,107 against profit from operating activities of LKR 186,233,971, net profit before taxation of LKR 167,975,268, net profit of LKR 103,360,405 or LKR 16.97 per share on revenue of LKR 506,902,395 for the same period a year ago. Cash used in operating activities of LKR 18,503,693 against cash generated from operating activities of LKR 22,979,138 for the same period a year ago. Purchases of property, plant and equipment of LKR 20,688,826 against LKR 1,000,500 for the same period a year ago.